| Kelsey Ann Wendland, CCC-SLP | |
|
180 Little Lake Dr Ste 4, Ann Arbor, MI 48103-6219 | |
| (224) 305-3024 | |
| Not Available |
| Full Name | Kelsey Ann Wendland |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 180 Little Lake Dr Ste 4, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720537269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7101007956 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelsey Ann Wendland, CCC-SLP 180 Little Lake Dr Ste 4, Ann Arbor, MI 48103-6219 Ph: (224) 305-3024 | Kelsey Ann Wendland, CCC-SLP 180 Little Lake Dr Ste 4, Ann Arbor, MI 48103-6219 Ph: (224) 305-3024 |
News Archive
Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.
A team of neuroscientists at the Champalimaud Centre for the Unknown, in Lisbon, has been able to map single neural connections over long distances in the brain.
Forest Laboratories, Inc today presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftaroline for the treatment of community-acquired pneumonia (CAP) in hospitalized patients.
Researchers have generated the first immortalised cell lines which allow more efficient manufacture of red blood cells.
› Verified 1 days ago
Ms. Irene Delyth Balmer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3200 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-677-0070 Fax: 734-677-0890 | |
Melissa A Buck, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 N Staebler Rd Ste B, Ann Arbor, MI 48103 Phone: 734-252-6522 Fax: 844-272-1304 | |
Mrs. Dana Lynn Hanifan, MA, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-7068 Fax: 734-615-1532 | |
Amanda Sheridan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Catherine St, Ann Arbor, MI 48109 Phone: 734-764-8440 | |
Mrs. Amy Elizabeth Lupo, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3370 E Morgan Rd, Ann Arbor, MI 48108 Phone: 810-814-5691 | |
April Cowden, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Va Ann Arbor Healthcare System, Ann Arbor, MI 48105 Phone: 614-440-3311 | |
Ms. Ann Lauria Lauria, M.A. CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5840 Interface Dr Ste 400, Ann Arbor, MI 48103 Phone: 734-627-8001 |